BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/24/2026 9:20:53 AM | Browse: 34 | Download: 146
Publication Name World Journal of Clinical Oncology
Manuscript ID 123328
Country India
ISSN 2218-4333 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Retrospective Cohort Study
Article Title Genomic landscape and clinical actionability of renal cell carcinoma in an Indian cohort: A real-world targeted next-generation sequencing study
Manuscript Source Unsolicited Manuscript
All Author List Vineet Talwar, Arpit Jain, Varun Goel, Bhumi Agarwal, Prateek Gupta, Rupal Tripathi, Sudhir Rawal and Anurag Mehta
ORCID
Author(s) ORCID Number
Vineet Talwar http://orcid.org/0000-0001-9149-6969
Arpit Jain http://orcid.org/0000-0002-3916-4411
Varun Goel http://orcid.org/0000-0003-3590-3261
Bhumi Agarwal http://orcid.org/0009-0001-3801-2893
Prateek Gupta http://orcid.org/0009-0005-3429-2499
Rupal Tripathi http://orcid.org/0000-0003-2007-2450
Sudhir Rawal http://orcid.org/0000-0002-3331-2372
Anurag Mehta http://orcid.org/0000-0001-6517-3664
Funding Agency and Grant Number
Corresponding Author Arpit Jain, Consultant, Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Sector -5, Rohini, New Delhi 110085, India. jain.arpit@rgcirc.org
Key Words Clear cell renal cell carcinoma; Next-generation sequencing; Precision oncology; Real-world data; European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets
Core Tip Renal cell carcinoma (RCC) demonstrates significant molecular heterogeneity; however, genomic data from Indian patients remain limited. In this real-world single-center study, targeted next-generation sequencing identified recurrent alterations in VHL, PBRM1, SETD2, ATM, and TP53, with concurrent VHL-PBRM1 mutations representing the most frequent co-alteration pattern. Potentially actionable alterations, primarily involving the PI3K-AKT-mTOR pathway, were detected in a subset of patients based on the European Society for Medical Oncology Scale for Clinical Actionability of Molecular Targets. These findings provide important insights into the genomic profile and therapeutic implications of RCC in an underrepresented population.
Publish Date 2026-08-24 09:20
Citation

Talwar V, Jain A, Goel V, Agarwal B, Gupta P, Tripathi R, Rawal S, Mehta A. Genomic landscape and clinical actionability of renal cell carcinoma in an Indian cohort: A real-world targeted next-generation sequencing study. World J Clin Oncol 2026; 17(8): 123328

URL https://www.wjgnet.com/2218-4333/full/v17/i8/123328.htm
DOI https://doi.org/10.5306/wjco.123328
Full Article (PDF) WJCO-17-123328-with-cover.pdf